Edit P.
- Country
- Austria
- Department
- Department of Medicine I Division of hematology and hemostaseology
Research Overview
- Safety and Tolerability Assessment of Odronextamab and Cemiplimab in Adult Patients with B-Cell Non-Hodgkin’s Lymphoma
- A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY TO COMPARE THE EFFICACY AND SAFETY OF ODRONEXTAMAB (REGN1979), AN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY, VERSUS INVESTIGATOR’S CHOICE IN PREVIOUSLY UNTREATED PARTICIPANTS WITH FOLLICULAR LYMPHOMA (OLYMPIA-1)
- A Phase 3 Randomized Study Comparing Odronextamab and Lenalidomide Versus Rituximab and Lenalidomide in Relapsed/Refractory Follicular and Marginal Zone Lymphoma
Data & Insights
Has run more than one trial at 71 of 147 partner sites.
Specializations
Hematology and Blood Disorders
The investigator is active in clinical research on malignant and non-malignant hematologic conditions, with interest in lymphoma, leukemia, multiple myeloma, myelodysplastic syndromes, and myelofibrosis. The portfolio also includes inherited and acquired bleeding and clotting disorders such as haemophilia, von Willebrand disease, immune thrombocytopenia, and thrombotic thrombocytopenic purpura.
- Diffuse large B-cell lymphoma
- Relapsed/refractory multiple myeloma
- Chronic lymphocytic leukemia
- Immune thrombocytopenia
Work in this area extends to CAR T-cell therapy, antibody-based approaches, and other innovative treatments for advanced or relapsed blood cancers.
Gastroenterology, Hepatology, and Inflammatory Bowel Disease
Clinical activity includes treatment-focused research in Crohn’s disease, ulcerative colitis, primary sclerosing cholangitis, cirrhosis, and portal hypertension. The disease spectrum also covers immune-mediated digestive disorders and chronic liver conditions with unmet therapeutic need.
- Crohn’s disease
- Ulcerative colitis
- Primary sclerosing cholangitis
- Portal hypertension
The research landscape reflects interest in immune modulation, fibrotic liver disease, and advanced therapies for chronic gastrointestinal inflammation.
Cardiovascular and Renal Medicine
The investigator is involved in studies spanning cardiovascular disease, heart failure, atherosclerotic disease, atrial fibrillation, and kidney disease, including kidney transplantation and antibody-mediated rejection. This area also includes vascular risk reduction and protection of organ function in complex comorbidity settings.
- Chronic kidney disease
- Kidney transplantation
- Heart failure
- Atherosclerotic cardiovascular disease
Therapeutic interests include cardiorenal protection, transplant immunology, and interventions aimed at preserving cardiovascular and renal outcomes.
Autoimmune, Inflammatory, and Neuromuscular Diseases
Research involvement extends across systemic immune-mediated disorders such as rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome, systemic sclerosis, and vasculitis. Neuromuscular and neuroimmunologic conditions also feature prominently, including myasthenia gravis, inflammatory myopathies, and chronic inflammatory demyelinating polyneuropathy.
- Systemic lupus erythematosus
- Sjögren’s syndrome
- Generalized myasthenia gravis
- Chronic inflammatory demyelinating polyneuropathy
The therapeutic focus includes immune-targeted therapy for chronic inflammatory disease and organ-threatening autoimmune involvement.
Oncology, Transplantation, and Rare Disease
The investigator also contributes to research in solid tumors and rare disorders, including breast cancer, lung cancer, urothelial carcinoma, prostate cancer, and melanoma, alongside rare conditions such as amyloidosis, hereditary angioedema, and Fabry disease. Transplant-related studies further broaden this landscape with focus on post-transplant complications and immune control.
- Breast cancer
- Non-small cell lung cancer
- Urothelial carcinoma
- Transthyretin amyloid cardiomyopathy
This portfolio includes targeted oncology, cellular therapy, and treatments for rare systemic diseases with limited established options.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.